Hurley Capital’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Hurley Capital’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20	Closed	–	–	709
2025 Q2	$0	Buy	+20	New	–	﹤0.01%	506

Hurley Capital's RCPI Position: Q3 2025 in Review

Hurley Capital sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q3 2025, closing a stake of 20 shares.

Hurley Capital first reported a position in RCPI in Q2 2025 and held it in 1 quarter. The position peaked at $0 in Q2 2025. 0 funds tracked by Wall St. Rank hold RCPI as of Q3 2025.

Hurley Capital reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q3 2025 after selling out during the quarter.
Hurley Capital sold 20 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q3 2025.
Hurley Capital first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2025 and held it in 1 quarter.
Hurley Capital's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $0 in Q2 2025.
0 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q3 2025.

Based on Hurley Capital's 13F filing for Q3 2025, filed 12 Nov 2025.